DNA antisense therapy for asthma in an animal model View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-02

AUTHORS

Jonathan W. Nyce, W. James Metzger

ABSTRACT

Asthma is an inflammatory disease characterized by bronchial hyper-responsiveness that can proceed to life-threatening airway obstruction. It is one of the most common diseases in industrialized countries, and in the United States accounts for about 1% of all healthcare costs1. Asthma prevalence and mortality have increased dramatically over the past decade2, and occupational asthma is predicted to be the pre-eminent occupational lung disease in the next decade3. Increasing evidence suggests that adenosine, an endogenous purine that is involved in normal physiological processes, may be an important mediator of bronchial asthma4–15. In contrast to normal individuals, asthmatic individuals respond to adenosine challenge with marked airway obstruction6,7, and concentrations of adenosine are elevated in the bronchoalveolar lavage fluid of asthma patients9. We performed a randomized crossover study using the dust mite-conditioned allergic rabbit model of human asthma. Administration of an aerosolized phosphorothioate antisense oligodeoxynucleotide targeting the adenosine A1 receptor desensitized the animals to subsequent challenge with either adenosine or dust-mite allergen. More... »

PAGES

721-725

Journal

TITLE

Nature

ISSUE

6618

VOLUME

385

Related Patents

  • Methods Of Inhibiting Phagocytosis
  • Sequences With Unmethylated Cpg (Cytosine-Guanine) Dinucleotides That Modulate An Immune Response Including Stimulating A Th1 Pattern Of Immune Activation, Cytokine Production, Nk Lytic Activity, And B Cell Proliferation, Also
  • Immunostimulatory Nucleic Acid Molecules
  • Methods Of Using Immunostimulatory Nucleic Acid Molecules To Treat Allergic Conditions
  • Composition And Methods For The Pulmonary Delivery Of Nucleic Acids
  • Administering Nucleic Acid To Activate Surface Antigen; Anticancer Agents
  • Oligonucleotides Having A '5tcg Motif Without Any Additional Unmethylated Cpg Motifs Have Strong Immunostimulatory Capability
  • Modulating The Interaction Of Immune Complexes With Tissue Fc Receptors By Introducing An Inhibitor Of An Endogenous Kinase
  • For Extending Clinical Utility Of Ifn-Alpha In Treatment Of A Variety Of Viral And Proliferative Disorders; Invention Provides Methods Which Increase Efficacy Of Ifn- Alpha And Reduce Ifn- Alpha Treatment-Related Side Effects
  • Packaging Of Immunostimulatory Substances Into Virus-Like Particles: Method Of Preparation And Use
  • Low Adenosine Anti-Sense Oligonucleotide Agent, Composition, Kit And Treatments
  • Central Airway Administration For Systemic Delivery Of Therapeutics
  • Immunostimulatory Nucleic Acid Molecules
  • Treating Asthma, Diarrhea, Insulin Resistance, Diabetes, Ischemia/Reprefusion Injuries, Diabetic Retinopathy Or Hyperbaric Oxygen-Induced Retinopathy
  • Processes For Packaging Oligonucleotides Into Virus-Like Particles Of Rna Bacteriophages
  • Amide Substituted Pyrimidine Compound; Antiarthritic Agents; Antiischemic Agents; Antidiabetic Agents; Inflammatory Bowel Disease; Antiproliferative Agents; Antiallergens
  • Semi-Soft C-Class Immunostimulatory Oligonucleotides
  • Modulating The Clearance Of Antibody-Coated Cells From Circulation; Modulating The Interaction Of Immune Complexes With Tissue Fc Receptors; Modulating The Activation Of Immunological Processes
  • Administering Immunopotentiating Cytokine Selected From Group Consisting Of Gm-Csf, Il-2, Il-4 And Ifn-.Gamma., And Immunostimulatory Cpg Oligonucleotide For Inducing Synergistic Antigen Specific Immune Response
  • Compositions And Their Uses Directed To Thymus And Activation-Regulated Chemokine (Tarc)
  • For Therapy Of Asthma, Allergic Rhinitis, Respiratory System Disorders
  • 4-Heterocyclo-Pyrrolo[2,3d] Pyrimidine Compositions And Their Use
  • Compounds Specific To Adenosine A3 Receptor And Uses Thereof
  • Immunostimulatory Nucleic Acid Molecules
  • Compounds Specific To Adenosine A1 Receptor And Uses Thereof
  • Antisense Modulation Of P38 Mitogen Activated Protein Kinase Expression
  • Inhibitors Of Endothelin-1 Synthesis
  • Oligo Is Antisense To The Initiation Codon, The Coding Region Or The 5' And 3' Intronexon Junctions Of A Gene Encoding The Adenosine A.Sub.1 Receptor Or Antisense To An Adenosine A.Sub.1 Receptor Mrna; And
  • Compounds Specific To Adenosine A3 Receptor And Uses Thereof
  • Contacting Dendritic Cell With An Isolated Nucleic Acid Containing At Least One Unmethylated Cpg Dinucleotide Wherein The Nucleic Acid Is From 8-80 Bases In Length In An Amount Effective To Activate Dendritic Cell
  • Immunostimulatory Nucleic Acid Molecules
  • Compounds Specific To Adenosine A1 Receptors And Uses Thereof
  • Single-Stranded Antisense Oligonucleotide With Modified Internucleoside Phosphorothioate Linkage Or A 2'-O-(2-Methoxyethyl)(2'-Moe) Modified Sugar Moiety; May Have 5-Methylcytosine Modified Nucleobase; Antiallergen, Antiasthmatic, Antiinflammatory And Antihistamine Agents; Respiratory System Disorders
  • Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity
  • Pyrrolopyrimidine A2b Selective Antagonist Compounds, Their Synthesis And Use
  • Method Of Treating Cancer Using Immunostimulatory Oligonucleotides
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • For Extending Clinical Utility Of Interferon (Ifn) Alpha In Treatment Of A Variety Of Viral And Proliferative Disorders; Increase Efficacy Of Ifn- Alpha And Reduce Ifn- Alpha Treatment-Related Side Effects
  • Use Of Nucleic Acids Containing Unmethylated Cpc Dinucleotide In The Treatment Of Lps-Associated Disorders
  • 4-Aminopyrrolo[2,3-D]Pyrimidine Compounds Specific To Adenosine A2a Receptor And Uses Thereof
  • Compositions And Their Uses Directed To Il-4r Alpha
  • Immunostimulatory Nucleic Acid Packaged Particles For The Treatment Of Hypersensitivity
  • Cardiovascular Disorders; Central Nervous System Disorders
  • Ameliorating An Immune System Deficiency In A Subject, Comprising The Steps Of Contacting Lymphocytes Obtained From The Subject With An Antigen And An Immunostimulatory Nucleic Acid
  • Modified Polynucleotides Have At Least One Phosphorothioate Linkage; Animal Growth Regulators; Immunomodulation, Immunotherapy; Nontoxic
  • Introducing Into Phagocytic Cells That Are In Contact With Immune Complexes An Inhibitor Of A Kinase Endogenous To Said Cells Associated With An Fc Receptor Present At The Membrane Of Said Cells
  • Low Adenosine Anti-Sense Oligonucleotide, Compositions, Kit And Method For Treatment Of Airway Disorders Associated With Bronchoconstriction, Lung Inflammation, Allergy(Ies) And Surfactant Depletion
  • Packaging Of Immunostimulatory Substances Into Virus-Like Particles: Method Of Preparation And Use
  • Pyrrolo[2,3d]Pyrimidine Compositions And Their Use
  • Use Of Nucleic Acids Containing Unmethylated Cpg Dinucleotide As An Adjuvant
  • Antagonists Of A2b Adenosine Receptors For Treatment Of Inflammatory Bowel Disease
  • Composition, Formulations & Method For Prevention & Treatment Of Diseases And Conditions Associated With Bronchoconstriction, Allergy(Ies) & Inflammation
  • Nucleic Acids Containing Unmethylated Cytosine-Guanine Dinucleotides Activate Lymphocytes And Redirect An Immune Response From Th2 To Th1
  • Modulation Of Stat 6 Expression
  • Pyrimidine A2b Selective Antagonist Compounds, Their Synthesis And Use
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • Semi-Soft C-Class Immunostimulatory Oligonucleotides
  • Processes For Packaging Aggregated Oligonucleotides Into Virus-Like Particles Of Rna Bacteriophages
  • Low Adenosine Agent, Composition, Kit And Method For Treatment Of Airway Disease
  • Low Adenosine Anti-Sense Oligonucleotide, Compositions, Kit & Method For Treatment Of Airway Disorders Associated With Bronchoconstriction, Lung Inflammation, Allergy(Ies) & Surfactant Depletion
  • Modulate Immunology Response; Asthma Therapy; Autoimmune Disease
  • Methods And Products For Inducing Mucosal Immunity
  • Compounds Specific To Adenosine A3 Receptor And Uses Thereof
  • A Dna With The Intron-Exon Junctions Encoding An Adenosine A1 Receptor Or An Adenosine A3 Receptor; Treating Asthma, Allergy
  • Antisense Inhibition Of Human Stat-6
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/385721a0

    DOI

    http://dx.doi.org/10.1038/385721a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1019304458

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9034188


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adenosine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Administration, Inhalation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigens, Dermatophagoides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Asthma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bronchial Hyperreactivity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross-Over Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA, Antisense", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Models, Animal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lung", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Purinergic P1 Receptor Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rabbits", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Purinergic P1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Respiratory Function Tests", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Molecular Pharmacology and Therapeutics, EpiGenesis Pharmaceuticals, 27834, Greenville, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Molecular Pharmacology and Therapeutics, EpiGenesis Pharmaceuticals, 27834, Greenville, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nyce", 
            "givenName": "Jonathan W.", 
            "id": "sg:person.01207550562.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207550562.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacology, School of Medicine, East Carolina University, 27858, Greenville, North Carolina, USA", 
              "id": "http://www.grid.ac/institutes/grid.255364.3", 
              "name": [
                "Department of Medicine, Section of Allergy, Asthma and Immunology, East Carolina University, 27858, Greenville, North Carolina, USA", 
                "Department of Pharmacology, School of Medicine, East Carolina University, 27858, Greenville, North Carolina, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Metzger", 
            "givenName": "W. James", 
            "id": "sg:person.01357627635.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357627635.84"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf02028098", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005996334", 
              "https://doi.org/10.1007/bf02028098"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/372333a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031628023", 
              "https://doi.org/10.1038/372333a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1997-02", 
        "datePublishedReg": "1997-02-01", 
        "description": "Asthma is an inflammatory disease characterized by bronchial hyper-responsiveness that can proceed to life-threatening airway obstruction. It is one of the most common diseases in industrialized countries, and in the United States accounts for about 1% of all healthcare costs1. Asthma prevalence and mortality have increased dramatically over the past decade2, and occupational asthma is predicted to be the pre-eminent occupational lung disease in the next decade3. Increasing evidence suggests that adenosine, an endogenous purine that is involved in normal physiological processes, may be an important mediator of bronchial asthma4\u201315. In contrast to normal individuals, asthmatic individuals respond to adenosine challenge with marked airway obstruction6,7, and concentrations of adenosine are elevated in the bronchoalveolar lavage fluid of asthma patients9. We performed a randomized crossover study using the dust mite-conditioned allergic rabbit model of human asthma. Administration of an aerosolized phosphorothioate antisense oligodeoxynucleotide targeting the adenosine A1 receptor desensitized the animals to subsequent challenge with either adenosine or dust-mite allergen.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/385721a0", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6618", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "385"
          }
        ], 
        "keywords": [
          "life-threatening airway obstruction", 
          "allergic rabbit model", 
          "bronchoalveolar lavage fluid", 
          "occupational lung disease", 
          "adenosine A1 receptors", 
          "dust mite allergen", 
          "phosphorothioate antisense oligodeoxynucleotides", 
          "marked airway", 
          "airway obstruction", 
          "occupational asthma", 
          "asthmatic individuals", 
          "concentration of adenosine", 
          "human asthma", 
          "crossover study", 
          "asthma prevalence", 
          "lavage fluid", 
          "lung disease", 
          "inflammatory diseases", 
          "A1 receptors", 
          "endogenous purines", 
          "animal models", 
          "asthma", 
          "subsequent challenge", 
          "normal physiological processes", 
          "rabbit model", 
          "normal individuals", 
          "important mediator", 
          "common disease", 
          "disease", 
          "antisense oligodeoxynucleotides", 
          "antisense therapy", 
          "adenosine", 
          "physiological processes", 
          "airway", 
          "obstruction", 
          "therapy", 
          "allergens", 
          "mortality", 
          "prevalence", 
          "individuals", 
          "administration", 
          "receptors", 
          "United States", 
          "mediators", 
          "animals", 
          "oligodeoxynucleotides", 
          "evidence", 
          "study", 
          "contrast", 
          "fluid", 
          "concentration", 
          "purine", 
          "challenges", 
          "countries", 
          "model", 
          "costs1", 
          "state", 
          "process"
        ], 
        "name": "DNA antisense therapy for asthma in an animal model", 
        "pagination": "721-725", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1019304458"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/385721a0"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9034188"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/385721a0", 
          "https://app.dimensions.ai/details/publication/pub.1019304458"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:21", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_267.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/385721a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/385721a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/385721a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/385721a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/385721a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    202 TRIPLES      21 PREDICATES      102 URIs      92 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/385721a0 schema:about N462ec4d6e59848eb8cd611bcb1438a5f
    2 N51c8dcff65354d928753eecde187d9b4
    3 N59d17656a2584387923196fec567400d
    4 N60c2180fe0184ca590573662180e574e
    5 N731869886a874676a751a94ad3cdcd5b
    6 N770682edb6924695a619b0707aee55b8
    7 N8431f84698f04ad0b6957787bf995002
    8 N88498f5dc4a74f5da87294863028ab61
    9 N9351e5f275e6455e9f4c0646fbe2d5ba
    10 N939bf9e07eb048b2831f0ff0006896e9
    11 N9d35cbcfa5ef4c7e831a5d841a9c000f
    12 Nc4505d1dc40d48e498de7ff9ba29e753
    13 Nd584c9ea1524478fb20f87f8d93f1e5f
    14 Ndc7b990a9c6a4bd386d87f352bd6e2ff
    15 Nf6547e6d90dc4801b34dd3335f5a3388
    16 Nf81cac1371cb46f794922b864434d467
    17 anzsrc-for:11
    18 anzsrc-for:1102
    19 schema:author N913bb3a12d4749178c01df60f0df0f7b
    20 schema:citation sg:pub.10.1007/bf02028098
    21 sg:pub.10.1038/372333a0
    22 schema:datePublished 1997-02
    23 schema:datePublishedReg 1997-02-01
    24 schema:description Asthma is an inflammatory disease characterized by bronchial hyper-responsiveness that can proceed to life-threatening airway obstruction. It is one of the most common diseases in industrialized countries, and in the United States accounts for about 1% of all healthcare costs1. Asthma prevalence and mortality have increased dramatically over the past decade2, and occupational asthma is predicted to be the pre-eminent occupational lung disease in the next decade3. Increasing evidence suggests that adenosine, an endogenous purine that is involved in normal physiological processes, may be an important mediator of bronchial asthma4–15. In contrast to normal individuals, asthmatic individuals respond to adenosine challenge with marked airway obstruction6,7, and concentrations of adenosine are elevated in the bronchoalveolar lavage fluid of asthma patients9. We performed a randomized crossover study using the dust mite-conditioned allergic rabbit model of human asthma. Administration of an aerosolized phosphorothioate antisense oligodeoxynucleotide targeting the adenosine A1 receptor desensitized the animals to subsequent challenge with either adenosine or dust-mite allergen.
    25 schema:genre article
    26 schema:isAccessibleForFree false
    27 schema:isPartOf N018f39284ced40578c060df4791127d0
    28 Nf8cca4a1d2b04e22b0fcc20433af4e15
    29 sg:journal.1018957
    30 schema:keywords A1 receptors
    31 United States
    32 adenosine
    33 adenosine A1 receptors
    34 administration
    35 airway
    36 airway obstruction
    37 allergens
    38 allergic rabbit model
    39 animal models
    40 animals
    41 antisense oligodeoxynucleotides
    42 antisense therapy
    43 asthma
    44 asthma prevalence
    45 asthmatic individuals
    46 bronchoalveolar lavage fluid
    47 challenges
    48 common disease
    49 concentration
    50 concentration of adenosine
    51 contrast
    52 costs1
    53 countries
    54 crossover study
    55 disease
    56 dust mite allergen
    57 endogenous purines
    58 evidence
    59 fluid
    60 human asthma
    61 important mediator
    62 individuals
    63 inflammatory diseases
    64 lavage fluid
    65 life-threatening airway obstruction
    66 lung disease
    67 marked airway
    68 mediators
    69 model
    70 mortality
    71 normal individuals
    72 normal physiological processes
    73 obstruction
    74 occupational asthma
    75 occupational lung disease
    76 oligodeoxynucleotides
    77 phosphorothioate antisense oligodeoxynucleotides
    78 physiological processes
    79 prevalence
    80 process
    81 purine
    82 rabbit model
    83 receptors
    84 state
    85 study
    86 subsequent challenge
    87 therapy
    88 schema:name DNA antisense therapy for asthma in an animal model
    89 schema:pagination 721-725
    90 schema:productId N060333fcd2b7472fa89e79ffa83afa96
    91 Nb8b9dddb3ae448728e8f689bca7b65f2
    92 Ne0a2169429424291a9395309235ed9d2
    93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019304458
    94 https://doi.org/10.1038/385721a0
    95 schema:sdDatePublished 2022-12-01T06:21
    96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    97 schema:sdPublisher N3de5b3ca4b6b4cbea916e90a481a88b2
    98 schema:url https://doi.org/10.1038/385721a0
    99 sgo:license sg:explorer/license/
    100 sgo:sdDataset articles
    101 rdf:type schema:ScholarlyArticle
    102 N018f39284ced40578c060df4791127d0 schema:volumeNumber 385
    103 rdf:type schema:PublicationVolume
    104 N060333fcd2b7472fa89e79ffa83afa96 schema:name doi
    105 schema:value 10.1038/385721a0
    106 rdf:type schema:PropertyValue
    107 N3de5b3ca4b6b4cbea916e90a481a88b2 schema:name Springer Nature - SN SciGraph project
    108 rdf:type schema:Organization
    109 N462ec4d6e59848eb8cd611bcb1438a5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Rabbits
    111 rdf:type schema:DefinedTerm
    112 N51c8dcff65354d928753eecde187d9b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Purinergic P1 Receptor Antagonists
    114 rdf:type schema:DefinedTerm
    115 N59d17656a2584387923196fec567400d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Humans
    117 rdf:type schema:DefinedTerm
    118 N60c2180fe0184ca590573662180e574e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Receptors, Purinergic P1
    120 rdf:type schema:DefinedTerm
    121 N731869886a874676a751a94ad3cdcd5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Cross-Over Studies
    123 rdf:type schema:DefinedTerm
    124 N770682edb6924695a619b0707aee55b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Asthma
    126 rdf:type schema:DefinedTerm
    127 N8431f84698f04ad0b6957787bf995002 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Glycoproteins
    129 rdf:type schema:DefinedTerm
    130 N88498f5dc4a74f5da87294863028ab61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name DNA, Antisense
    132 rdf:type schema:DefinedTerm
    133 N913bb3a12d4749178c01df60f0df0f7b rdf:first sg:person.01207550562.19
    134 rdf:rest Nc1c00b55269044458d7a890fc968db5d
    135 N9351e5f275e6455e9f4c0646fbe2d5ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Bronchial Hyperreactivity
    137 rdf:type schema:DefinedTerm
    138 N939bf9e07eb048b2831f0ff0006896e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Administration, Inhalation
    140 rdf:type schema:DefinedTerm
    141 N9d35cbcfa5ef4c7e831a5d841a9c000f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Disease Models, Animal
    143 rdf:type schema:DefinedTerm
    144 Nb8b9dddb3ae448728e8f689bca7b65f2 schema:name pubmed_id
    145 schema:value 9034188
    146 rdf:type schema:PropertyValue
    147 Nc1c00b55269044458d7a890fc968db5d rdf:first sg:person.01357627635.84
    148 rdf:rest rdf:nil
    149 Nc4505d1dc40d48e498de7ff9ba29e753 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Adenosine
    151 rdf:type schema:DefinedTerm
    152 Nd584c9ea1524478fb20f87f8d93f1e5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Lung
    154 rdf:type schema:DefinedTerm
    155 Ndc7b990a9c6a4bd386d87f352bd6e2ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Animals
    157 rdf:type schema:DefinedTerm
    158 Ne0a2169429424291a9395309235ed9d2 schema:name dimensions_id
    159 schema:value pub.1019304458
    160 rdf:type schema:PropertyValue
    161 Nf6547e6d90dc4801b34dd3335f5a3388 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Respiratory Function Tests
    163 rdf:type schema:DefinedTerm
    164 Nf81cac1371cb46f794922b864434d467 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Antigens, Dermatophagoides
    166 rdf:type schema:DefinedTerm
    167 Nf8cca4a1d2b04e22b0fcc20433af4e15 schema:issueNumber 6618
    168 rdf:type schema:PublicationIssue
    169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    170 schema:name Medical and Health Sciences
    171 rdf:type schema:DefinedTerm
    172 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    173 schema:name Cardiorespiratory Medicine and Haematology
    174 rdf:type schema:DefinedTerm
    175 sg:journal.1018957 schema:issn 0028-0836
    176 1476-4687
    177 schema:name Nature
    178 schema:publisher Springer Nature
    179 rdf:type schema:Periodical
    180 sg:person.01207550562.19 schema:affiliation grid-institutes:None
    181 schema:familyName Nyce
    182 schema:givenName Jonathan W.
    183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207550562.19
    184 rdf:type schema:Person
    185 sg:person.01357627635.84 schema:affiliation grid-institutes:grid.255364.3
    186 schema:familyName Metzger
    187 schema:givenName W. James
    188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357627635.84
    189 rdf:type schema:Person
    190 sg:pub.10.1007/bf02028098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005996334
    191 https://doi.org/10.1007/bf02028098
    192 rdf:type schema:CreativeWork
    193 sg:pub.10.1038/372333a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031628023
    194 https://doi.org/10.1038/372333a0
    195 rdf:type schema:CreativeWork
    196 grid-institutes:None schema:alternateName Department of Molecular Pharmacology and Therapeutics, EpiGenesis Pharmaceuticals, 27834, Greenville, North Carolina, USA
    197 schema:name Department of Molecular Pharmacology and Therapeutics, EpiGenesis Pharmaceuticals, 27834, Greenville, North Carolina, USA
    198 rdf:type schema:Organization
    199 grid-institutes:grid.255364.3 schema:alternateName Department of Pharmacology, School of Medicine, East Carolina University, 27858, Greenville, North Carolina, USA
    200 schema:name Department of Medicine, Section of Allergy, Asthma and Immunology, East Carolina University, 27858, Greenville, North Carolina, USA
    201 Department of Pharmacology, School of Medicine, East Carolina University, 27858, Greenville, North Carolina, USA
    202 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...